No abstract

The field of tissue engineering is an emerging discipline which applies the basic principles of life sciences and engineering to repair and restore living tissues and organs. The purpose of this study was to investigate the effect of cold and non-thermal plasma surface modification of poly (ϵ-caprolactone) (PCL) scaffolds on fibroblast cell behavior. Nano-fiber PCL was fabricated through electrospinning technique, and some fibers were then treated by cold and non-thermal plasma. The cell-biomaterial interactions were studied by culturing the fibroblast cells on nano-fiber PCL. Scaffold biocompatibility test was assessed using an inverted microscope. The growth and proliferation of fibroblast cells on nano-fiber PCL were analyzed by MTT viability assay. Cellular attachment on the nano-fiber and their morphology were evaluated using scanning electron microscope. The result of cell culture showed that nano-fiber could support the cellular growth and proliferation by developing three-dimensional topography. The present study demonstrated that the nano-fiber surface modification with cold plasma sharply enhanced the fibroblast cell attachment. Thus, cold plasma surface modification greatly raised the bioactivity of scaffolds.

No abstract

No abstract

Cell attachment and differentiation on biomaterials might be enhanced by surface modification techniques. The main aim of this study was to improve stem cell/material interaction by pressure cold atmospheric plasma (CAP). We developed a combination of electrospun poly (ε‐caprolactone) (PCL)‐chitosan (CTS) and PCL‐carboxy methyl chitosan (CMC) scaffolds. In order to make nanofiber surfaces more appropriate for mesenchymal stem cell (MSC) attachment and proliferation, CAP was used. Proliferation and cartilage differentiation of MSCs were then evaluated during 21 days. Biocompatibility test, scanning electron microscopy (SEM) analysis, 3‐[4,5‐dimethylthiazol‐2yl]‐2, 5‐diphenyl tetrazolium bromide (MTT) and 4′,6‐diamidino‐2‐phenylindole (DAPI) staining were performed. After 21 days, induction of cartilage differentiation was approved through expression of SRY‐Box 9 (SOX9) and collagen type II (COL2) genes by reverse transcription polymerase chain reaction (RT‐PCR), and COL2 protein expression was accordingly confirmed by immunocytochemistry (ICC). Thus, our data showed the PCL/CMC scaffolds can support and induce the differentiation of MSC to cartilage‐like cells.